Chengdu Kanghong Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000020C4
CNY
30.97
0.45 (1.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,237.10
1,185.42
1,024.97
1,105.52
1,183.62
1,079.58
940.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,237.10
1,185.42
1,024.97
1,105.52
1,183.62
1,079.58
940.73
Raw Material Cost
152.96
156.67
146.18
136.26
150.87
146.51
145.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
599.26
506.06
467.49
522.07
585.78
463.80
434.13
Other Expenses
11.46
8.86
23.14
14.32
11.71
5.20
15.77
Total Expenditure (Excl Depreciation)
866.86
751.37
845.11
801.50
853.80
662.27
736.83
Operating Profit (PBDIT) excl Other Income
370.20000000000005
434.09999999999997
179.89999999999998
304
329.79999999999995
417.29999999999995
203.9
Other Income
22.19
29.30
36.35
17.36
43.53
28.45
48.73
Operating Profit (PBDIT)
450.00
523.23
273.19
380.40
430.71
503.87
310.44
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-0.92
-0.96
0.33
-0.42
-1.24
0.27
-0.61
Gross Profit (PBDT)
1,084.14
1,028.75
878.79
969.27
1,032.75
933.07
795.73
Depreciation
59.32
59.32
59.02
59.02
58.11
58.11
58.16
Profit Before Tax
389.75
462.94
214.50
320.97
371.37
446.03
251.67
Tax
64.42
66.18
2.25
42.52
56.26
74.51
36.80
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
329.68
400.02
217.52
281.49
318.70
373.52
219.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
329.68
400.02
217.52
281.49
318.70
373.52
219.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.44
-3.39
-5.40
-3.14
-3.64
-2.05
-4.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
325.24
396.62
212.12
278.35
315.06
371.48
214.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,862.97
9,054.67
8,653.20
8,435.51
8,153.76
8,177.53
7,804.03
Earnings per share (EPS)
0.36
0.43
0.24
0.31
0.35
0.41
0.24
Diluted Earnings per share
0.36
0.43
0.24
0.31
0.35
0.41
0.24
Operating Profit Margin (Excl OI)
29.79%
36.66%
17.35%
27.5%
27.8%
38.66%
21.64%
Gross Profit Margin
36.3%
44.06%
26.69%
34.37%
36.28%
46.7%
32.93%
PAT Margin
26.65%
33.74%
21.22%
25.46%
26.93%
34.6%
23.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.36% vs 15.65% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -18.00% vs 86.99% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -13.38% vs 108.57% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Chengdu Kanghong Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,237.10
0
1,237.10
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,237.10
0
1,237.10
Raw Material Cost
152.96
0
152.96
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
599.26
0
599.26
Other Expenses
11.46
0.00
11.46
Total Expenditure (Excl Depreciation)
866.86
0
866.86
Operating Profit (PBDIT) excl Other Income
370.24
0.00
370.24
Other Income
22.19
0
22.19
Operating Profit (PBDIT)
450.00
0
450.00
Interest
0.00
0
0.00
Exceptional Items
-0.92
0
-0.92
Gross Profit (PBDT)
1,084.14
0
1,084.14
Depreciation
59.32
0
59.32
Profit Before Tax
389.75
0
389.75
Tax
64.42
0
64.42
Provisions and contingencies
0
0
0.00
Profit After Tax
329.68
0
329.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
329.68
0
329.68
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.44
0
-4.44
Other related items
0.00
0.00
0.00
Consolidated Net Profit
325.24
0
325.24
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,862.97
0
8,862.97
Earnings per share (EPS)
0.36
0
0.36
Diluted Earnings per share
0.36
0
0.36
Operating Profit Margin (Excl OI)
29.79%
0%
0.00
29.79%
Gross Profit Margin
36.30%
0%
0.00
36.30%
PAT Margin
26.65%
0%
0.00
26.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 123.71 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.36% vs 15.65% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4.52% vs 16.42% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 32.52 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -18.00% vs 86.99% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.21% vs 29.94% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.78 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -13.38% vs 108.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.49% vs 26.49% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.79%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024